ATH 0.00% 0.5¢ alterity therapeutics limited

Ann: Safety Outcomes of Alzheimer's IMAGINE Extension Trial, page-12

  1. 1,494 Posts.
    lightbulb Created with Sketch. 93

    It says its talking to FDA and OTHER agencies for initiation of phase 3 - with 2 year safety data behind it EMA is a good back up plan. Its good to hav them confirm they are initiating those talks at the same time.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $8.75K 1.75M

Buyers (Bids)

No. Vol. Price($)
59 63306661 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28430837 21
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.